Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming?

INTRODUCTION: Interstitial lung disease (ILD) is a frequent extra-articular manifestation of Rheumatoid arthritis (RA), but nowadays there are no randomized controlled clinical trials to support therapeutic guidelines. RA-ILD, especially with UIP pattern, shares some similarities with idiopathic pul...

Descripción completa

Detalles Bibliográficos
Autores principales: Cassone, Giulia, Sebastiani, Marco, Vacchi, Caterina, Cerri, Stefania, Salvarani, Carlo, Manfredi, Andreina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150508/
https://www.ncbi.nlm.nih.gov/pubmed/32292694
http://dx.doi.org/10.1016/j.rmcr.2020.101051

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7150508/
https://www.ncbi.nlm.nih.gov/pubmed/32292694
http://dx.doi.org/10.1016/j.rmcr.2020.101051

Ejemplares similares